Role of tumor necrosis factor-α in the human systemic endotoxin-induced transcriptome
- PMID: 24236088
- PMCID: PMC3827317
- DOI: 10.1371/journal.pone.0079051
Role of tumor necrosis factor-α in the human systemic endotoxin-induced transcriptome
Abstract
TNFα has been implicated in the pathogenesis of various inflammatory diseases. Different strategies to inhibit TNFα in patients with sepsis and chronic inflammatory conditions have shown contrasting outcomes. Although TNFα inhibitors are widely used in clinical practice, the impact of TNFα antagonism on white blood cell gene expression profiles during acute inflammation in humans in vivo has not been assessed. We here leveraged the established model of human endotoxemia to examine the effect of the TNFα antagonist, etanercept, on the genome-wide transcriptional responses in circulating leukocytes induced by intravenous LPS administration in male subjects. Etanercept pre-treatment resulted in a markedly dampened transcriptional response to LPS. Gene co-expression network analysis revealed this LPS-induced transcriptome can be categorized as TNFα responsive and non-responsive modules. Highly significant TNFα responsive modules include NF-kB signaling, antiviral responses and T-cell mediated responses. Within these TNFα responsive modules we delineate fundamental genes involved in epigenetic modifications, transcriptional initiation and elongation. Thus, we provide comprehensive information about molecular pathways that might be targeted by therapeutic interventions that seek to inhibit TNFα activity during human inflammatory diseases.
Conflict of interest statement
Figures
Similar articles
-
Transcriptome kinetics of circulating neutrophils during human experimental endotoxemia.PLoS One. 2012;7(6):e38255. doi: 10.1371/journal.pone.0038255. Epub 2012 Jun 5. PLoS One. 2012. PMID: 22679495 Free PMC article.
-
Enhanced susceptibility to lipopolysaccharide-induced arthritis and endotoxin shock in interleukin-32 alpha transgenic mice through induction of tumor necrosis factor alpha.Arthritis Res Ther. 2012 May 21;14(3):R120. doi: 10.1186/ar3850. Arthritis Res Ther. 2012. PMID: 22613074 Free PMC article.
-
Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model.J Nutr. 1998 Dec;128(12):2334-40. doi: 10.1093/jn/128.12.2334. J Nutr. 1998. PMID: 9868178
-
Thymoquinone attenuates proinflammatory responses in lipopolysaccharide-activated mast cells by modulating NF-kappaB nuclear transactivation.Biochim Biophys Acta. 2007 Apr;1770(4):556-64. doi: 10.1016/j.bbagen.2007.01.002. Epub 2007 Jan 12. Biochim Biophys Acta. 2007. PMID: 17292554
-
A PEGylated Fab' fragment against tumor necrosis factor for the treatment of Crohn disease: exploring a new mechanism of action.BioDrugs. 2008;22(5):331-7. doi: 10.2165/00063030-200822050-00005. BioDrugs. 2008. PMID: 18778114 Review.
Cited by
-
LPS-induced modules of co-expressed genes in equine peripheral blood mononuclear cells.BMC Genomics. 2017 Jan 5;18(1):34. doi: 10.1186/s12864-016-3390-y. BMC Genomics. 2017. PMID: 28056766 Free PMC article.
-
The leukocyte non-coding RNA landscape in critically ill patients with sepsis.Elife. 2020 Dec 11;9:e58597. doi: 10.7554/eLife.58597. Elife. 2020. PMID: 33305733 Free PMC article.
-
Leukocyte transcriptional signatures dependent on LPS dosage in human endotoxemia.J Leukoc Biol. 2019 Nov;106(5):1153-1160. doi: 10.1002/JLB.4A0219-050R. Epub 2019 Jul 7. J Leukoc Biol. 2019. PMID: 31280495 Free PMC article. Clinical Trial.
-
Treatment with etanercept and low monocyte concentration contribute to the risk of invasive aspergillosis in patients post allogeneic stem cell transplantation.Sci Rep. 2019 Nov 21;9(1):17231. doi: 10.1038/s41598-019-53504-8. Sci Rep. 2019. PMID: 31754120 Free PMC article.
-
HIVEP1 Is a Negative Regulator of NF-κB That Inhibits Systemic Inflammation in Sepsis.Front Immunol. 2021 Nov 5;12:744358. doi: 10.3389/fimmu.2021.744358. eCollection 2021. Front Immunol. 2021. PMID: 34804025 Free PMC article.
References
-
- Aggarwal BB (2003) Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunology 3: 745–756. - PubMed
-
- Bradley JR (2008) TNF-mediated inflammatory disease. J Pathol. 214: 149–160. - PubMed
-
- Reinhart K, Karzai W (2001) Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned. Crit Care Med. 29: S121–125. - PubMed
-
- Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, et al. (2006) Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295: 2275–2285. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
